Patients With Established Cardiovascular Disease Injectable semaglutide currently has more mature cardiovascular outcome data
This effect was observed without any impact on the marker expression of Lgr5 + stem cells, goblet cells, and Paneth cells
Marc Jean-Gilles, DO, FACOG Breaks Down How Long It Takes for Semaglutide to Suppress Appetite Will I notice a decrease in my appetite immediately after my first semaglutide injection
Effective January 1, 2026, Medi-Cal Rx is excluding coverage for GLP-1 medications prescribed for weight loss: [12] Wegovy, Zepbound, Saxenda: Completely removed from the Contract Drugs List for weight loss Ozempic, Mounjaro, Rybelsus: Restricted to Type 2 diabetes onlyweight loss claims will auto-deny Existing prior authorizations end December 31, 2025 Exceptions: Members under age 21 may still qualify via EPSDT Non-weight-loss indications (Zepbound for OSA, Wegovy for cardiovascular) may still get PA approval This does NOT affect Kaiser commercial or employer-sponsored plansonly Medi-Cal members
Some patients report headaches , particularly in the early treatment phase
